Nama Insights

State Street SPDR S&P Pharmaceuticals ETF (XPH)

Health · State Street Investment Management · NYSE

HealthETF
State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund in the Health category. It has $586.92M in assets, an expense ratio of 0.35% and a 0.47% dividend yield. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Assets under management$586.92M
Expense ratio0.35%
CategoryHealth
Dividend yield0.47%
NAV$66.94
Fund familyState Street Investment Management
ExchangeNYSE

Top holdings

The largest positions State Street SPDR S&P Pharmaceuticals ETF reports, by weight.

HoldingNameWeight
AMLX Amylyx Pharmaceuticals Inc 3.65%
CRNX Crinetics Pharmaceuticals Inc 3.61%
MBX MBX Biosciences Inc 2.90%
ATAI AtaiBeckley Inc 2.83%
OMER Omeros Corp 2.68%
DFTX Definium Therapeutics Inc Ordinary Shares 2.49%
ELVN Enliven Therapeutics Inc 2.28%
NUVB Nuvation Bio Inc Ordinary Shares - Class A 2.12%
CORT Corcept Therapeutics Inc 2.11%
ETON Eton Pharmaceuticals Inc 2.08%

Other Health ETFs

Explore live XPH data on Nama Insights →